Adaptive Biotechnologies Corp (ADPT) Stock Price Today
Overview
Financial
Technicals
Analysis
Corporate Action
About
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Technical Indicators
|
|
|
There are no indicators for the selected timeframe.
Performance
ADPT ROI
% from 52W High
52W Low: $2.34
18 Apr 2024
52W High: $6.83
30 Aug 2023
News
People Also Bought
US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions
Let’s trade or invest in this asset by signing up or logging in!
You can also download our app!
